Furthermore, in vitro and in vivo experiments clearly show that Δ12-PGJ3 differed from the synthetic agonist of DP1 receptor, ZK118182, in terms of its ability to induce airways hyperresponsiveness, release of histamine, and IL-4 expression, which are all associated with hypersensitivity. This evidence concerns the gene IL4 and airway hyperresponsiveness.